A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

Clinical trial NCT02412917 · TERMINATED

Trial details

NCT number: NCT02412917
Sponsor: ContraVir Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Shingles Herpes Zoster Postherpetic Neuralgia

Start date: 2015-06-01
Primary completion: 2017-11-01
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.